Joint pain is an incurable chronic disease, which more than 350 million people suffer from globally. The global joint pain injection market reached US$ 4.71 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.8%. Our micro-robotic injection solution can precisely deliver micro-robots with stem cells to joint lesions. The stem cell loaded on the micro-robot facilitates the regeneration of cartilage to cure joint pain due to cartilage degeneration. We will partner with local medical institutions in preclinical and clinical trials to provide non-invasive and regenerative therapy for people to restore their healthy joints.
Dr Chen Shuxun* (Research Associate, Dept. of Biomedical Engineering, CityU)
Mr Wang Chongyun (PhD student, Dept. of Biomedical Engineering, CityU)
Ms Huo Yingxin (PhD student, Dept. of Biomedical Engineering, CityU)
Mr Henry Lam Wah-shing (PhD student, Dept. of Biomedical Engineering, CityU)
* Person-in-charge
(Info based on the team's application form)
- CityU HK Tech 300 Seed Fund (2022)